We also described for the first time the overexpression of MEF2C and its translocation into the nucleus, which suggest a supporting role in the development of brain metastasis from BC for this transcription factor, predicted to be a target of both miR‐802‐5p and miR‐194‐5p. This evidence concerns the gene MEF2C and breast cancer.